Acclaimed comedian and actor Jon Lovitz is talking candidly for the first time about living with severe plaque psoriasis through a national disease awareness campaign called Are You Serious?™. Psoriasis is a chronic autoimmune condition which causes red, scaly plaques on the skin and affects nearly 7.5 million Americans, including Lovitz, who struggled with the condition for 10 years before getting its symptoms under control. Through his distinctive comedic style, Lovitz illustrates several of the everyday challenges faced by people with psoriasis in TV and radio public service announcements (PSAs), an entertaining song parody performed to Maroon 5’s famous hit, “This Love,” and an educational website – SeriousAboutPsoriasis.com.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/seriousaboutpsoriasis/47521/
International treatment guidelines – from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) – have advised that prevention of exacerbations should be a cornerstone of COPD management, placing equal emphasis on the management of future risk as it does on treatment of COPD symptoms.1 This is also confirmed in the latest data on the impact of season on the frequency of COPD exacerbations, showing an almost two-fold increase in the winter months. This is contributing to the increased morbidity seen during the festive season.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/nycomedtakeda/52782/
BNY Mellon, the global leader in asset management and securities servicing, today announced that it is launching a $6 million global workforce development initiative over five years to assist vulnerable youth making the transition into adulthood.
As part of the global initiative, BNY Mellon will collaborate with leading public and non-profit agencies in the United States, United Kingdom and Asia to enhance education, job training and career development opportunities for this population at risk for severe challenges including chronic unemployment, poverty and homelessness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bnymellon/47038/
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
A new survey from the nonprofit Gout & Uric Acid Education Society (GUAES) highlights an alarming awareness gap among Americans regarding the risk factors for gout, a chronic, potentially disabling form of arthritis which now affects an estimated 8.3 million Americans. Among the survey findings are that only one in 10 Americans correctly cited cardiovascular disease as a risk factor for gout, while only one in three Americans correctly reported that obesity is a risk factor, and less than one in five reported that diabetes and kidney disease are risk factors. GUAES released the survey findings in advance of its annual Gout Awareness Day on May 22.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gouteducation/49664/
According to a recent national survey, 17.1 percent of Americans lack health insurance, and more than nine million of the nation’s uninsured rely on federally qualified health centers (FQHC), non-profit community clinics and free clinics each year for primary care. While these clinics serve the critical health care needs of the uninsured, patients oftentimes cannot afford the medications prescribed by the clinic’s physicians, or navigate a fragmented system that only offers partial solutions. This is a particularly growing problem for America’s working poor.
Today, Medco Foundation and Dispensary of Hope (DOH), a not-for-profit pharmacy-focused social venture for the uninsured, introduced a new, national initiative to substantially improve the supply, delivery and management of critical prescription drugs to thousands of uninsured Americans who are managing a chronic illness.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54424-medco-dispensary-of-hope-prescription-drug-program-clinics-uninsured
Each year, more than 51 million school hours are lost as a result of problems related to tooth decay, the most common chronic childhood disease in America.1 Yet according to a recent survey by Trident®, more than eight in 10 (84%) American parents don’t realize this.2 That is why Trident, in partnership with Oral Health America’s Smiles Across America® program (SAA), and actor Chris O’Donnell announced today in Los Angeles that they are teaming up to help fight cavities among the nation’s youth and address the need for oral disease prevention services.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/trident/45632/
Starting in November, fans of BC and Goody's Headache Powders and country music superstar Trace Adkins and racing legend Richard Petty, will have another opportunity to help honor and empower wounded service members as well as children with chronic medical conditions. Utilizing the power of Facebook, fans can go to BC and Goody's Facebook pages to help raise funds for Wounded Warrior Project (WWP) and Victory Junction. For every BC or Goody's page
When it comes to their health, nearly 90 percent of Americans lack the literacy skills to understand basic medical information and instruction. Low literacy has been linked to poor health outcomes such as higher rates of hospitalization and less frequent use of preventive services. A few quick minutes with a physician is not sufficient for most of us to understand a complex or chronic medical condition and how we can manage it. But new research indicates that video storytelling can be an effective way to educate people about health conditions - and watching others share their health stories can empower people to take control of their own health.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/besmartbewell/50819/
JAFRA USA, a leader in empowering women personally and professionally through a career in direct selling, is partnering with Beauty Bus Foundation, a national non-profit organization that brings dignity, hope and respite through beauty and grooming services to those who need pampering the most – people with chronic and terminal illness and their caregivers. JAFRA USA has selected Beauty Bus Foundation, an organization founded by women entrepreneurs, as its national charity given its shared mission to impact lives through beauty.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55834-jafra-usa-beauty-bus-foundation-empowering-women-chronic-terminal-illness
Ortho Clinical Diagnostics (OCD), in partnership with the National Association of Chronic Disease Directors (NACDD), today unveiled new consumer survey results and a report revealing the state of blood test health literacy in the United States with strategies to support much-needed patient education and empowerment. The first step: ensuring patient access to and understanding of blood test results, a critical component to maintaining health and wellness. The campaign kicks off during National Health Literacy Month, an awareness effort founded in 1999 to promote the importance of understandable health information.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52662-ortho-clinical-diagnostics-and-nacdd-blood-test-health-literacy-survey
Today, politicians, patients and health and work experts of the Fit for Work Europe Coalition added their voices to national advocates from across Europe for their countries to take bold steps to reduce the staggering €240 billion economic burden of chronic musculoskeletal disorders (MSDs) to European society.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/fitforwork/52154/
